|
|
Article: Postmenopausal Women With Osteoporosis Treated With Actonel for Five Years Have Bone Mineralization Comparable to Younger, Premenopausal Women.
- Article from:
- PR Newswire
- Article date:
- October 4, 2004
CopyrightCOPYRIGHT 2004 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
SEATTLE, Oct. 4 /PRNewswire/ -- In postmenopausal women with osteoporosis, treatment with Actonel(R) (risedronate sodium tablets) improves then maintains bone mineralization at levels comparable to those of premenopausal women. Mineralization is a property of bone that contributes to bone strength. These new data, generated collaboratively by researchers at the Mayo Clinic College of Medicine and The Alliance for Better Bone Health, were presented at the 26th Annual Meeting of the American Society for Bone and Mineral Research (ASBMR).
"We know from other diseases that there is an optimal range of bone mineralization," said Russell T. Turner, Ph.D., Professor, ...